ARTICLE | Clinical News
Onconase pancreatic enzyme: Phase I/II results in 245 patients
September 26, 1994 7:00 AM UTC
Alfacell Corp. (ACEL), Bloomfield, N.J. Product: Onconase pancreatic enzyme Indication: Pancreatic cancer Status: Phase I/II results in 245 patients of the agent in combination with tamoxifen have be...